In contrast, a mouse model for heart failure and AF showed that the protective effect of BGP-15 was independent of HSPA1 and HSPB1, but attributed the drug’s protective role to the phosphorylation of insulin-like growth factor 1 (IGF-1) receptor [56]. This evidence concerns the gene HSPA1A and atrial fibrillation.